Factor VIIa-antithrombin complexes in patients with arterial and venous thrombosis

Thrombosis and Haemostasis

Volumn 103, Issue 6, 2010, Pages 1188-1192

  Spiezia, Luca ^a   Rossetto, Valeria ^a   Campello, Elena ^a   Gavasso, Sabrina ^a   Woodhams, Barry ^b   Tormene, Daniela ^a   Simioni, Paolo ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b R and D Diagnostica Stago   (France)

Author keywords

Arterial thrombosis; Factor VIIa AT complexes; Venous thrombosis

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7A; MULTIPROTEIN COMPLEX; PROTEIN BINDING;

ADULT; AGED; ANTITHROMBIN DEFICIENCY; ARTERY THROMBOSIS; ARTICLE; BLOOD CLOTTING FACTOR 7 DEFICIENCY; COMPLEX FORMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOSTASIS; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PROTEIN INTERACTION; VEIN THROMBOSIS; ADOLESCENT; BLOOD; BLOOD CLOTTING DISORDER; GENETICS; METABOLISM; MIDDLE AGED; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTITHROMBINS; COAGULATION PROTEIN DISORDERS; FACTOR V; FACTOR VIIA; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPROTEIN COMPLEXES; PROTEIN BINDING; VENOUS THROMBOSIS;

EID: 77953166584     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH09-08-0606     Document Type: Article

References (16)

1. Nemerson Y, Repke D. Tissue factor accelerates the activation of coagulation factor VII: the role of a bifunctional coagulation cofactor. Thromb Res 1985; 40: 351-358.
2. Broze GJ Jr, Girard TJ, Novotny WF. Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochem 1990; 29: 7539-7546.
3. Rapaport SI. The extrinsic pathway inhibitor: a regulator of tissue factor-dependent blood coagulation. Thromb Haemost 1991; 66: 6-15.
4. Salemink I, Franssen J, Willems GM, et al. Factor Xa cleavage of tissue factor pathway inhibitor is associated with loss of anticoagulant activity. Thromb Haemost. 1998; 80: 273-280. (Pubitemid 28393623)
5. Bajaj MS, Birktoft JJ, Steer SA, et al. Structure and biology of tissue factor pathway inhibitor. Thromb Haemost. 2001; 86: 959-972. (Pubitemid 32975818)
6. Kondo S, Kisiel W. Regulation of factor VIIa activity in plasma: evidence that antithrombin III is the sole plasma protease inhibitor of human factor VIIa. Thromb Res 1987; 46: 325-335.
7. Rao LV, Rapaport SI, Hoang AD. Binding of factor VIIa to tissue factor permits rapid antithrombin III/heparin inhibition of factor VIIa. Blood 1993; 81: 2600-2607.
8. Lawson JH, Butenas S, Ribarik N, et al. Complex-dependent inhibition of factor VIIa by antithrombin III and heparin. J Biol Chem 1993; 268: 767-770. (Pubitemid 23019699)
9. Broze GJ Jr, Likert K, Higuchi D. Inhibition of factor VIIa/tissue factor by antithrombin III and tissue factor pathway inhibitor. Blood 1993; 82: 1679-1680. (Pubitemid 23263990)
10. Jesty J, Lorenz A, Rodriguez J, et al. Initiation of the tissue factor pathway of coagulation in the presence of heparin: control by antithrombin III and tissue factor pathway inhibitor. Blood 1996; 87: 2301-2307. (Pubitemid 26086870)
11. Iakhiaev A, Ruf W, Rao LV. The role of catalytic cleft and exosite residues of factor VIIa for complex formation with tissue factor pathway inhibitor. Thromb Haemost 2001; 85: 458-463. (Pubitemid 32233019)
12. Rao LV, Nordfang O, Hoang AD. et al. Mechanism of antithrombin III inhibition of factor VIIa/tissue factor activity on cell surfaces. Comparison with tissue factor pathway inhibitor/factor Xa-induced inhibition of factor VIIa/tissue factor activity. Blood 1995; 85: 121-129.
13. Smith SA , Antonaci FC, Woodhams BJ, et al. Factor VIIA-antithrombin complexes in human plasma. XXI Congress of the International Society on Thrombosis and Haemostasis in Geneva, Switzerland, July 2007. J Thromb Haemost 2007; 5 (Suppl 2): Abstract O-S-040.
14. Miller GJ, Ireland HA, Cooper JA, et al. Relationship between markers of activated coagulation, their correlation with inflammation, and association with coronary heart disease (NPHSII). J Thromb Haemost 2008; 6: 259-267.
15. Bilgen D, Sönmez H, Ekmekci H, et al. The relationship of TFPI, Lp(a), and oxidized LDL antibody levels in patients with coronary artery disease. Cl Bioch 2005; 38: 92-96.
16. Roubey RAS, Lovell T, Morrissey JH. Elevated plasma levels of factor VIIA-antithrombin complexes in patients with antiphospholipid antibodies. XXI Congress of the International Society on Thrombosis and Haemostasis in Geneva, Switzerland, July 2007. J Thromb Haemost 2007; 5 (Suppl 2): Abstract P-T-431.